Form 4: Alignment Healthcare CEO John Kao Sells 90,000 Shares

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at a price of $19.0969 per share on April 14, 2025, according to a Form 4 filing.

Summary

• John Kao, the CEO of Alignment Healthcare, sold 90,000 shares of the company's common stock on April 14, 2025.
• The sale price was $19.0969 per share.
• Following the transaction, Mr. Kao directly owns 4,923,186 shares and indirectly owns 2,003,100 shares through the JEK Trust dated February 8, 2021, of which he is the trustee.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 14, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a standard transaction (stock sale) by an executive under a pre-arranged plan. It doesn't inherently indicate positive or negative company performance.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, potentially leading to short-term price fluctuations.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. They can be driven by various factors, including personal financial planning and diversification strategies. The use of Rule 10b5-1 plans allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.

Stakeholder Impact

• The stock sale could have a minor short-term impact on shareholder sentiment.

Key Dates

Keywords

Form 4, stock sale, John Kao, Alignment Healthcare, ALHC, CEO, Rule 10b5-1